Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study.
Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study.
复制标题
DOI:
10.1007/s00259-022-05848-z
复制
发表时间:
2022-10
影响因子:
9.1
通讯作者:
Rindi, Guido
中科院分区:
文献类型:
--
作者:
Rufini, Vittoria;Lorusso, Margherita;Inzani, Frediano;Pasciuto, Tina;Triumbari, Elizabeth Katherine Anna;Grillo, Lucia Rosalba;Locco, Filippo;Margaritora, Stefano;Pescarmona, Edoardo;Rindi, Guido
关键词:
To correlate somatostatin receptor (SSTR) and proliferative activity profile (SSTR2, SSTR5, Ki-67) at immunohistochemistry (IHC) with SSTR-PET/CT imaging features in a retrospective series of lung neuroendocrine tumors (NET). Proliferative activity by Ki-67 and 18F-FDG-PET/CT parameters (when available) were also correlated. Among 551 patients who underwent SSTR-PET/CT with 68Ga-DOTA-somatostatin analogs (SSA) between July 2011 and March 2020 for lung neuroendocrine neoplasms, 32 patients with a confirmed diagnosis of NET were included. For 14 of them, 18F-FDG-PET/CT was available. PET/CT images were reviewed by qualitative and semi-quantitative analyses. Immunohistochemistry for SSTR2, SSTR5, and Ki-67 was assessed. Inferential analysis was performed including kappa statistics and Spearman’s rank correlation test. Definitive diagnosis consisted of 26 typical carcinoids-G1 and six atypical carcinoids-G2. Positive SSTR2-IHC was found in 62.5% of samples while SSTR5-IHC positivity was 19.4%. A correlation between SSTR2-IHC and SSTR-PET/CT was found in 24/32 cases (75.0%, p = 0.003): 20 were concordantly positive, 4 concordantly negative. For positive IHC, 100% concordance with SSTR-PET/CT (both positive) was observed, while for negative IHC concordance (both negative) was 33.3%. In 8 cases, IHC was negative while SSTR-PET/CT was positive, even though with low-grade uptake in all but one. A significant correlation between SUVmax values at SSTR-PET/CT and the SSTR2-IHC scores was found, with low SUVmax values corresponding to negative IHC and higher SUVmax values to positive IHC (p = 0.002). This retrospective study showed an overall good agreement between SSTR2-IHC and tumor uptake at SSTR-PET/CT in lung NETs. SSTR-PET/CT SUVmax values can be used as a parameter of SSTR2 density. Within the limits imposed by the relatively small cohort, our data suggest that SSTR2-IHC may surrogate SSTR-PET/CT in selected lung NET patients for clinical decision making when SSTR-PET/CT is not available.
登录
查看更多内容
影响因子:
50.5
作者:
Righi, L.;Volante, M.;Papotti, M.
通讯作者:
Papotti, M.
影响因子:
5.5
作者:
Hofman, Michael S.;Lau, W. F. Eddie;Hicks, Rodney J.
通讯作者:
Hicks, Rodney J.
DOI:
10.1038/s41379-018-0110-y
发表时间:
2018-12
期刊:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
影响因子:
--
作者:
Rindi G;Klimstra DS;Abedi-Ardekani B;Asa SL;Bosman FT;Brambilla E;Busam KJ;de Krijger RR;Dietel M;El-Naggar AK;Fernandez-Cuesta L;Klöppel G;McCluggage WG;Moch H;Ohgaki H;Rakha EA;Reed NS;Rous BA;Sasano H;Scarpa A;Scoazec JY;Travis WD;Tallini G;Trouillas J;van Krieken JH;Cree IA
通讯作者:
Cree IA
影响因子:
9.3
作者:
Duijzentkunst, Daan A. Smit;Kwekkeboom, Dik J.;Bodei, Lisa
通讯作者:
Bodei, Lisa
影响因子:
9.6
作者:
Fink, G;Krelbaum, T;Kramer, MR
通讯作者:
Kramer, MR